Lynn Kee

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

DNA damage response deficiency enhances neuroblastoma progression and sensitivity to combination PARP and ATR inhibition.

DNA damage response deficiency enhances neuroblastoma progression and sensitivity to combination PARP and ATR inhibition.

Journal: Cell reports
Published: October 11, 2024

Comparative single-cell transcriptomic profiling of patient-derived renal carcinoma cells in cellular and animal models of kidney cancer.

Comparative single-cell transcriptomic profiling of patient-derived renal carcinoma cells in cellular and animal models of kidney cancer.

Journal: FEBS open bio
Published: September 05, 2024

SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma.

SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma.

Journal: Cancer research communications
Published: May 23, 2023

Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial.

Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial.

Journal: Cancers
Published: May 20, 2022

Vitamin D Receptor Activation Attenuates Hippo Pathway Effectors and Cell Survival in Metastatic Neuroblastoma.

Vitamin D Receptor Activation Attenuates Hippo Pathway Effectors and Cell Survival in Metastatic Neuroblastoma.

Journal: Molecular cancer research : MCR
Published: June 08, 2021

NRAS Status Determines Sensitivity to SHP2 Inhibitor Combination Therapies Targeting the RAS-MAPK Pathway in Neuroblastoma.

NRAS Status Determines Sensitivity to SHP2 Inhibitor Combination Therapies Targeting the RAS-MAPK Pathway in Neuroblastoma.

Journal: Cancer research
Published: December 10, 2019

Extracellular domain shedding of the ALK receptor mediates neuroblastoma cell migration.

Extracellular domain shedding of the ALK receptor mediates neuroblastoma cell migration.

Journal: Cell reports
Published: December 10, 2019

A Metastatic Mouse Model Identifies Genes That Regulate Neuroblastoma Metastasis.

A Metastatic Mouse Model Identifies Genes That Regulate Neuroblastoma Metastasis.

Journal: Cancer research
Published: June 02, 2016

SATB2 enhances migration and invasion in osteosarcoma by regulating genes involved in cytoskeletal organization.

SATB2 enhances migration and invasion in osteosarcoma by regulating genes involved in cytoskeletal organization.

Journal: Oncogene
Published: February 04, 2014
Showing 1-9 of 9

Last Updated: 09/26/2026